A5056796340- Atrial Fibrillation Management and Outcomes
- Diabetes Management and Research
- Diabetes Treatment and Management
- Cardiac Arrhythmias and Treatments
- Diet and metabolism studies
- Pancreatic function and diabetes
- Cardiac Imaging and Diagnostics
- Pharmacology and Obesity Treatment
- Colorectal and Anal Carcinomas
- Metabolism, Diabetes, and Cancer
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Cardiac pacing and defibrillation studies
- Coronary Interventions and Diagnostics
- Anorectal Disease Treatments and Outcomes
- Colorectal Cancer Surgical Treatments
- Hernia repair and management
- Cardiac tumors and thrombi
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Heart Failure Treatment and Management
- Gastric Cancer Management and Outcomes
- Pelvic and Acetabular Injuries
- Lipoproteins and Cardiovascular Health
- Non-Invasive Vital Sign Monitoring
- Lung Cancer Diagnosis and Treatment
Universidade Federal de Santa Catarina
2022-2025
Universidade Federal do Rio Grande do Sul
2024
Instituto Dante Pazzanese de Cardiologia
2024
Escola Bahiana de Medicina e Saúde Pública
2024
Beth Israel Deaconess Medical Center
2024
Harvard University
2024
Universidade Federal de Campina Grande
2024
Boston Medical Center
2024
Universidade Federal do Triângulo Mineiro
2024
Shaare Zedek Medical Center
2004
Abstract Background Treatment of atrial fibrillation (AF) with catheter ablation (CA) has evolved significantly. However, real-world data on long-term outcomes are limited, particularly in low- and middle-income countries. Objective This multicenter prospective cohort consecutive patients aimed to evaluate the safety efficacy first-time CA for AF Southern Brazil from 2009 2024. Methods The primary outcome was any tachyarrhythmia (ATA) recurrence. Multivariable Cox proportional hazards model...
Treatment of atrial fibrillation (AF) with catheter ablation (CA) has evolved significantly. However, real-world data on long-term outcomes are limited, particularly in low- and middle-income countries. This multicenter prospective cohort consecutive patients aimed to evaluate the safety efficacy first-time CA for AF Southern Brazil from 2009 2024. The primary outcome was any tachyarrhythmia (ATA) recurrence. Multivariable Cox proportional hazards model assessed independent predictors Among...
Abstract Background The benefit of adding Zolbetuximab to the treatment in patients with Claudin-18 isoform 2 (CLDN18.2)-positive, human epidermal growth factor receptor 2-negative, locally advanced unresectable or metastatic gastric gastro-oesophageal junction adenocarcinoma (GC/GEJ) is not yet fully elucidated. Methods We searched PubMed, Embase and Cochrane databases for randomized controlled trials (RCTs) that investigated plus chemotherapy versus alone GC GEJ adenocarcinoma. computed...
This systematic review and meta-analysis investigated the efficacy safety of fezolinetant for treatment moderate-to-severe vasomotor symptoms (VMS) associated with menopause. PubMed, Cochrane Library, Embase Web Science were searched randomized controlled trials (RCTs) published from inception to June 2023, comparing placebo in postmenopausal women suffering VMS. The mean difference risk ratio calculated continuous binary outcomes, respectively. R software was used statistical analysis,...
The aim of this study was to assess the efficacy and safety hybrid closed-loop (HCL) systems for insulin delivery in children adolescents with type 1 diabetes (T1D). We searched Embase, PubMed, Cochrane Library randomized controlled trials (RCTs) published until March 2023 comparing HCL therapy control therapies T1D. computed weighted mean differences (WMDs) continuous outcomes risk ratios (RRs) 95% confidence intervals (CIs) binary endpoints. [...]